Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 8 December 2022 to Question 97699 on Coronavirus: Immunosuppression, what assessment his Department has made of the adequacy of measures to protect people with a compromised immune system from serious illness due to COVID-19; and if he will make a statement.

The independent Joint Committee on Vaccination and Immunisation (JCVI) advises that those with severe immunosuppression should be offered three primary doses of a COVID-19 vaccination and keeps this advice under continuous review. The Government has made a range of new treatment options available in the community for patients at greater risk from COVID-19. This includes two oral antivirals and the intravenous antiviral, remdesivir. Patients in hospital with COVID-19 continue to have multiple treatment options, including dexamethasone, tocilizumab or sarilumab.